What move does the options market price into Oruka Therapeutics's report?

Implied ±4.0%, either direction.

ORKANasdaqPharmaceutical Preparations

Oruka Therapeutics, Inc. (ORKA) earnings date, market-implied expected move, and options open interest by expiry

99.80

+4.37 · +4.58%

Regular session12:36 ET

Open96.51Volume634,040Mkt cap$6.4BEPS-1.05

Day96.51 – 100.2688%52-wk25.23 – 115.5283%

ORKA

Oruka Therapeutics, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±4.0%implied · report alone

8Q avg ±3.6%·×1.10·fair

91.6099.26

straddle ±9.3%

spot 95.43exp Nov 20ATM strike 95ATM straddle 10.42IV 62%

Nov 2 closereport share · term structure

Expected move

Inputs

Next report

Nov 5

after close · in 2 days

est.Q3 FY26

Calendar

Next report

Last report

+6.40%

vs ±14.7% implied · ×0.44

shaded = implied · ▲▼ = realized

Aug 10 '26 · confirmed

Implied vs realized

Largest filed tie

filed ties

13F top-10 QoQ

+22.59%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

256 managers

Top fund weight

1.38%

ORKA weight · XBI

N-PORTJun 30 '26

4 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Oruka Therapeutics (ORKA) is expected to report on Nov 5 after close (estimated date).

Implied vs realized

8 reports

—≥ implied

Jul 21 '23Jul 21 '23confirmed—▼−0.49%—

Oct 18 '23Oct 18 '23confirmed—▼−0.49%—

Feb 1 '24Feb 1 '24confirmed—▲+2.55%—

Apr 25 '24Apr 25 '24confirmed—▲+2.87%—

Aug 1 '24Aug 1 '24confirmed—▲+5.07%—

Sep 5 '24Sep 5 '24confirmed—▲+2.80%—

Q1 FY26Apr 30 '26confirmed±11.0%▼−8.52%×0.78

Q2 FY26Aug 10 '26confirmed±14.7%▲+6.40%×0.44

quarterimplied−15%0+15%realized×

Q2 FY26±14.7%▲+6.40%×0.44

Q1 FY26±11.0%

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 5 expiries · Oct 28 close

0.05OI · 5 expiries · Oct 28 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

136+12%Nov 2017d2,742−11%

359−27%Dec 1845d1.65218+1%1.65

208+3%Jan 1573d0.93224−5%0.93

3,0110%Feb 19108d25.09120+3%25.09

1160%Mar 19136d0.31372+1%0.31

ExpiryPutsCallsP/C

Nov 2017d136+12%2,742−11%0.05

Dec 1845d359−27%218+1%1.65

Jan 1573d208+3%224−5%0.93

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±9.3%

Funds 4

XBI±0.1%

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 2 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 12:30 ET

Intraday

Event sensitivity

PCE ×1.36· ±4.4% vs ±3.3% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±4.4%10 of 19×1.36

GDPgross domestic product±4.0%11 of 19×1.21

NFPjobs report±2.8%5 of 10×0.87

FOMCrate decision±2.8%14 of 24×0.86

PPIproducer prices±2.7%6 of 10×0.82

CPIconsumer prices±2.5%5 of 10×0.78

CPROFcorporate profits±2.2%7 of 12×0.66

Bar = avg |move| to ±5% · tick = ±3.3% avg day · ×base = |move| ÷ ±3.3% · min 6 releases

Earnings history

EPS -93.54 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 10 '26 · confirmed	-93.54	—
Q1 FY26	Apr 30 '26 · confirmed	-80.58	—
Q3 FY25	—	-46.01	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod